Asia Pacific Antisense And Rnai Therapeutics Market Size & Outlook

Name: Asia Pacific Antisense And Rnai Therapeutics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The antisense and rnai therapeutics market in Asia Pacific is expected to reach a projected revenue of US$ 1,545.3 million by 2030. A compound annual growth rate of 17.7% is expected of Asia Pacific antisense and rnai therapeutics market from 2024 to 2030.

Biotechnology
- RNA analysis
  - Antisense And RNAi Therapeutics Market Outlook

Asia Pacific antisense and rnai therapeutics technology outlook (Revenue, USD million, 2018-2030)
- RNA Interference
- Antisense RNA
Asia Pacific antisense and rnai therapeutics application outlook (Revenue, USD million, 2018-2030)
- Neurodegenerative Disorders
- Genetic Disorders
- Cardiometabolic & Renal Disorders
- Ocular
- Cancer
- Skin Diseases
- Infectious Diseases
Asia Pacific antisense and rnai therapeutics route of administration outlook (Revenue, USD million, 2018-2030)
- Intravenous Injections
- Intrathecal Injections
- Subcutaneous Injections
- Other Delivery Methods

Asia Pacific Antisense And Rnai Therapeutics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!